Publications by authors named "P Fargeot"

Claim this Profile
P
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial.
A Fléchon, D Pouessel, C Ferlay, D Perol, P Beuzeboc, P Fargeot

Ann Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO).
F Rousseau, F Retornaz, F Joly, B Esterni, S Abadie-Lacourtoisie, P Fargeot

Crit Rev Oncol Hematol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma.
Jérôme Fayette, Nicolas Penel, Christine Chevreau, Jean-Yves Blay, Didier Cupissol, Pierre Fargeot

Invest New Drugs· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Germ cell testicular tumors: understanding the kinetics of serum human chorionic gonadotropin during chemotherapy].
J-M Riedinger, N Eche, P Fargeot

Ann Biol Clin (Paris)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy].
J-M Riedinger, N Eche, C Chevreau, P Fargeot

Ann Biol Clin (Paris)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis